The largest database of trusted experimental protocols

Lsrfortessa flow cytometry

Manufactured by BD
Sourced in United States

The BD LSRFortessa is a flow cytometry instrument that enables the analysis of cells or particles in a fluid sample. It is designed to measure various characteristics of cells, including size, granularity, and the expression of specific markers on their surface or within the cells. The BD LSRFortessa is capable of detecting multiple fluorescent signals simultaneously, allowing for the simultaneous analysis of multiple parameters.

Automatically generated - may contain errors

30 protocols using lsrfortessa flow cytometry

1

Neutrophil Oxidative Burst Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess the oxidative burst of neutrophils, we operated dihydrorhodamine123 (DHR123, Sigma Aldrich, Darmstadt, Germany) and phorbol 12-myristate 13-acetate (PMA) (Sigma Aldrich, Darmstadt, Germany). In all, 500 µL of peripheral blood in EDTA was RBC lysed, washed, and incubated with 5 pM of DHR for 5 min at 37 °C in a 5% CO2 atmosphere. Then, we added 50 nM of PMA and left the mixture for 15 min at 37 °C. Afterward, samples were incubated with antibodies against CD15 (APC, BD Biosciences, San Diego, CA, USA) and CD10 (APC-Cy7, ExBio) for 20 min at room temperature. Cells were washed and fixed in solution, and LSR Fortessa flow cytometry (BD Biosciences, San Diego, CA, USA) was performed. Approximately 500,000 events were obtained and analyzed with the FlowJo™ software (v.10.8.1).
+ Open protocol
+ Expand
2

Multiparametric Flow Cytometry of Mouse Hematopoiesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry was performed using the LSRFortessa Flow Cytometry (BD Bioscience), and the data analysed using FlowJo v7.6.5 (TreeStar) Software. The mouse antibodies TER119 (BD Bioscience), CD71 (clone RI7217, Biolegend), CD41 (clone MWReg30, BD Bioscience) and CD42a (clone Xia.B4, Emfret Analytics) were used at the concentrations recommended by the manufacturers.
+ Open protocol
+ Expand
3

Flow Cytometry Analysis of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
All gating strategy information is depicted in the Supplementary Fig. 8. Single cell suspensions from the indicated tissues were prepared as described above. Cells were resuspended in staining buffer (PBS, 1% FBS, 1 mM EDTA), followed by blocking of the Fc receptor and staining with the indicated antibodies for 30 min on ice in the dark. All antibodies used for flow cytometry (listed in Supplementary Table 2) were diluted as 1:200. For intracellular staining, cells were stained according to recommendations of the manufacturer of the eBioscience Foxp3 / Transcription Factor Staining Buffer Set (Cat No: 00-5523-00). Cells were washed and resuspended in staining buffer or PBS and either analyzed on LSRFortessa flow cytometry (BD Biosciences) or Canto flow cytometry (BD Bioscience). Data were analyzed with FlowJo V10.7.1(BD) software.
+ Open protocol
+ Expand
4

Dil-EMs Cytometry Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
MSCs and C28/I2 cells were treating with Dil-EMs for 2 h. Then the cell suspensions were collected and tested using a BD LSRFortessa Flow Cytometry. Flow data were then analyzed using FlowJo software.
+ Open protocol
+ Expand
5

Evaluation of Cellular Death in EPN and hAFSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cellular death was evaluated in EPN and hAFSCs cells incubated with DMEM-LG (negative control), Amblyomin-X [10 µM or 20 µM], Cisplatin [20 µM] for 24 or 48 h. In addition, as positive control, the cells were incubated with H2O2 [30%] for 30 minutes. Amounts of 105 EPNs cells or hAFSCs were twice washed with cold PBS. To labeling procedure, the cells were resuspended in 100 µL of Binding Buffer 1× (Molecular Probes, Invitrogen, USA), and were added FITC Annexin V (Molecular Probes, Invitrogen, USA) and 7-Amino-Actinomycin D (AAD – BD Biosciences), 5 µL each. The samples were incubated during 15 minutes in the dark at room temperature. Posteriorly, the volumes were adjusted to 500 µL using Binding Buffer 1×. Data acquisition was performed within one hour of labeling in LSRFortessa flow cytometry (BD Biosciences, San Jose, CA, USA) and analyzed by the software FlowJo.
+ Open protocol
+ Expand
6

In Vivo Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A single-cell suspension of splenocytes from naïve syngeneic mice was diluted to 1.5 × 108/ml in RPMI1640 containing 10% FBS and 2% penicillin and streptomycin pulsed at 37°C with or without 5 μg/ml peptides as described previously [19 (link)]. After 4 h, eflour450 (eBioscience, 65-0842-85) at 5 mM (high concentration) was used to label peptide-pulsed cells at room temperature in the dark. Non-peptide-pulsed cells were labelled with a low concentration of eflour450 at 0.5 mM. After being rinsed three times with PBS, 4 × 106 labelled and peptide-pulsed cells and an equal number of labelled non-peptide-pulsed cells were adoptively transferred by tail vein injections into mice that had previously been immunized. Six hours later, the percentage of labelled cells in spleens was detected with LSRFortessa flow cytometry (BD) and analyzed by FlowJo (TreeStar). The following formula calculated the specific cell lysis: Specific cell lysis ability% = (1-(percentage of cells incubated with peptide/percentage of cells incubated without peptide)) x100%.
+ Open protocol
+ Expand
7

Assessing Antigen-Specific Cell Lysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single suspensions of splenocytes from naïve syngeneic mice were diluted to 1.5*108/ml by RPMI1640 with 10% FBS and 2% Penicillin and Streptomycin, respectively, pulsed with or without 5 μg/ml peptides as mentioned above at 37°C. After 4 hours, a higher concentration of eflour450 (eBioscience, 65–0842-85) at 5 mM was used to label pulsed peptide cells. Cells without peptide-pulsed were labeled with a low concentration of eflour450 at 0.5 mM at room temperature in the dark. After being rinsed by PBS three times, 4*106 of labeled and peptides-pulsed cells and another equal number of labeled cells without peptide-pulsed were adoptive transferred by tail vein injections into mice previously immunized with different vaccines, respectively. Six hours later, the percentage of labeled cells was detected with LSRFortessa flow cytometry (BD) and analyzed by FlowJo (TreeStar). The following formula calculated the specific cell lysis: Specific cell lysis ability = (1-(percentage of cells incubated with peptide/percentage of cells incubated without peptide)) *100%.
+ Open protocol
+ Expand
8

Quantifying DR5 Expression in HCC-38 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCC-38 cells were seeded onto 60 mm plates and treated with L-AA (50, 100, and 200 μM) for 24 h. The cells were treated with trypsin-EDTA and centrifuged at 1000 rpm for 5 min. After washing with PBS, the cells were incubated with anti-death receptor 5 (DR5) primary antibody (Abcam, Cambridge, MA, USA, 1:100) in blocking buffer (2% FBS in PBS) for 30 min on ice. The cells were washed and stained with anti-Alexa Fluor-488 secondary antibody (Invitrogen, Carlsbad, CA, 1:1000) or rabbit IgG monoclonal isotype control (Abcam, Cambridge, MA, USA) in the dark for 30 min on ice. DR5-positive cells were detected using LSRFortessa flow cytometry (BD Bioscience, San Jose, CA, USA).
+ Open protocol
+ Expand
9

HMC-FMX Cytotoxicity Assay in 22Rv1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
After culturing 22Rv1 cells overnight at 37 °C, the cells were treated with HMC-FMX at 8.0 μg/mL [HMC] and incubated at various time points: 0.5, 3, or 6 hours. Media was removed from the wells and rinsed twice with PBS. Cells were then fixed with 4% PFA at RT for 10 min and stained with DAPI for 15 min at RT. The cells were imaged using a fluorescence microscope.
For flow cytometric study, 22Rv1 cells were cultured overnight at 37 °C, followed by treatment with HMC-FMX at 8.0 μg/mL [HMC]. After incubating at various time points: 0.5, 3, or 6 hours, the medium was removed, and the cells were harvested by trypsinization. Then, cells were rinsed twice with PBS and fixed with ice-cold 4% PFA for 15 min. Cells were resuspended in FACS buffer (1% FBS and 0.05% NaN3 in PBS) and analyzed by LSR Fortessa flow cytometry (BD Biosciences, San Jose, CA) to record the fluorescence histograms of HMC dyes.
+ Open protocol
+ Expand
10

Ovalbumin-specific B cell analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Draining lymph nodes (dLN; inguinal) were harvested 7 days after each immunization. Cells were stained with W614A-3S coupled with biotinylated ovalbumin (Ova) protein (Covalab) for 30 min at room temperature before cell surface antigen staining with a standard method after receptor Fc blocking with CD16/CD32 (clone 2.4G2; BD Biosciences, San Jose, CA, USA), and the following anti-mouse Abs: CD3e (clone 145-2C11; eBioscience, San Diego, CA, USA), CD45R/B220 (clone RA3-6B2), CD19 (clone 1D3), IgG1 (clone A85-1), IgD (clone 11-26c.2a), T- and B-cell activation antigen (clone GL7), and streptavidin (BD Biosciences). For cell analysis, dead cells were excluded by using the LIVE/DEAD fixable kit (Molecular Probes, Eugene, OR, USA). Cells were analyzed by BD LSRFortessa flow cytometry or isolated by BD FACSAria II sorter. A pool of five mice per condition at W3 and W5 was used for W614A-3S-specific B cell isolations (BioMark Dynamic array). A pool of 25 mice per condition at W11 was used for W614A-3S-specific IgG1+ GC (GL7+IgDLow) and NGC (GL7-IgD+) B cell isolations [chromium single cell V(D)J assay].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!